Kalaris Therapeutics, Inc. Common Stock
KLRS • NASDAQ • Stock Fundamentals
Kalaris Therapeutics, Inc. Common Stock is a publicly traded company trading on NASDAQ, led by CEO Andrew Oxtoby, with a market cap of $124.0M.
Market Cap$124.0M
CEOAndrew Oxtoby
CountryUnited States of America
Next EarningsAug 12, 2026 · in 2 monthsQ2 2026
Financials
KLR
Kalaris Therapeutics, Inc. Common Stock FAQ
Common questions about Kalaris Therapeutics, Inc. Common Stock
Kalaris Therapeutics, Inc. Common Stock (KLRS) has a market capitalization of $124.0M and trades on NASDAQ.